Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the APDS Telehealth topic
No spam. Unsubscribe anytime.
Board signals telehealth patients may use automated patient dispensing systems in medical offices
Summary
After a lengthy licensing‑committee discussion, the board indicated that patients seen by a practice via telehealth may receive prescriptions from an automated patient dispensing system located in that practice, while leaving broader placement and inspection rules for future regulatory work.
The California State Board of Pharmacy’s licensing discussion on April 30 clarified a key access question for automated patient dispensing systems (APDS): if a patient has a valid patient–prescriber relationship with a medical practice, the patient may receive medications from an APDS located within that practice even when the patient’s visit occurred via telehealth.
Legal counsel and multiple board members framed the issue as two separate questions: (1) where an APDS may be located and (2) which patients may be eligible to receive drugs from an APDS. The board reached consensus on the second question — that eligibility can be based on an established patient relationship rather than on whether the visit was in person or virtual. Counsel advised the board that an interpretive clarification of ‘‘patients of the practice’’ is easier to address now than a full redefinition of permissible locations for APDS devices, which may require formal rulemaking.
Members stressed that clarifying patient eligibility should not be misconstrued as allowing unrestricted placement of APDS units in arbitrary retail locations. Several members said they expect future work to refine the acceptable locations, contract relationships and inspection protocols for APDS units and to ensure monthly inspection requirements for covered‑entity placements are properly reflected in guidance and the self‑assessment form.
Public commenters including the American Telemedicine Association and provider groups urged the board to adopt clarity quickly to avoid disruption in access — particularly in pharmacy deserts where APDS kiosks can be the most timely option for newly prescribed medications.
What happens next: staff will update FAQ and self‑assessment materials and the enforcement committee will review inspection language; board members signaled willingness to consider regulations if outreach and education prove insufficient to remove ambiguity.
Attributions and accuracy: quotes and specific claims in this article are taken from public commenters and board members who self‑identified or were introduced in the meeting record.
